PPD, Inc. has opened an office in Novosibirsk, Russia, adding to its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location. The company also has offices in Moscow, Smolensk and St. Petersburg serving the growing markets of Central and Eastern Europe. “Establishing a presence in Novosibirsk allows us to serve clients more effectively and keep pace with clinical trial growth in this region,&#8...